News Year None2019201820172016201520132012201020092008 January 3, 2019 Merck Exercises Option for NGM Bio’s Investigational Insulin Sensitizer, NGM313, for the Treatment of NASH and Type 2 Diabetes Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 5 - 5 of 5
January 3, 2019 Merck Exercises Option for NGM Bio’s Investigational Insulin Sensitizer, NGM313, for the Treatment of NASH and Type 2 Diabetes
